TURKISH THORACIC JOURNAL, cilt.22, sa.6, ss.426-431, 2021 (ESCI)
OBJECTIVE: To compare class VII cystic fibrosis transmembrane conductance regulator (CFTR) mutations to class III-V mutations with regards to cystic fibrosis disease severity markers in children.